We present herein the pulse-chase analysis of the biosynthesis of the prohormone convertases PCI and PC2 in the endocrine GH4C1 cells infected with vaccinia virus recombinants expressing these convertases. Characterization of the pulse-labelled enzymes demonstrated that pro-PCI (88 kDa) is cleaved into PCI (83 kDa) and pro-PC2 (75 kDa) into PC2 (68 kDa). Secretion of glycosylated and sulphated PCI (84 kDa) occurs about 30 min after the onset of biosynthesis, whereas glycosylated and sulphated PC2 (68 kDa) is detected in the medium after between 1 and 2 h. Furthermore, in the case ofpro-PC2 only, we observed that a fraction of this precursor escapes glycosylation. A small proportion (about 5 %) of the intracellular glycosylated pro-PC2 (75 kDa) is sulphated, and it is this glycosylated and sulphated precursor that is cleaved into the secretable 68 kDa form of PC2.
INTRODUCTION
Cellular communication is accompanied by the release of bioactive peptides and proteins which act as the messengers or carriers of information. These active moieties are usually derived from inactive larger precursor proteins that undergo a number of post-translational modifications. Precursor processing at either pairs of or single basic residues represents one of the early post-translational events . Recently, the search for the proteinase(s) responsible for the cleavage of proproteins at pairs of basic residues culminated in the identification of six different gene products, representing mammalian kexin/subtilisin-like serine proteinases [1, 4] . These proprotein convertases were called PCI [5] (also called PC3 in [6] ), PC2 [7, 8] , furin [9] , PACE4 [10] , PC4 [11, 12] and PC5 [4,131. Analysis of the gene regulation [14, 15] and tissue distribution of some of these convertases demonstrated a unique pattern for each enzyme. Thus, whereas PCI and PC2 are only found in endocrine and neuroendocrine tissues and cells [4] [5] [6] [7] [8] 16] , furin [17, 18] and PACE4 [10] exhibit a ubiquitous tissue distribution and PC5 seems to localize only within a subset of endocrine and non-endocrine cells. In contrast, PC4 is expressed primarily within testicular germ cells, including round spermatids [11, 12] and pachytene spermatocytes [12] . The unique but widespread tissue distribution of the mRNA transcripts ofindividual mammalian kexin/subtilisin-like convertases suggests that each proteinase, either alone or in combination with the others, and in a tissue-specific manner, could potentially activate a variety of proproteins and prohormones [1, 4] . In this context, furin was reported to cleave efficiently precursors that are usually expressed in cells devoid of secretory granules, suggesting that this convertase is mostly involved in the processing of proproteins negotiating the constitutive pathway of secretion [19, 20] . In contrast, PCI and PC2 have been shown to represent major processing enzymes of prohormones destined to the regulated secretory pathway [21] [22] [23] , in agreement with the observed expression of these convertases primarily within endocrine and neuroendocrine tissues and cells [4] [5] [6] [7] [8] 14, 16, 21] .
The alignment of the sequences of PCI, PC2, furin, PACE4, PC4 and PC5 with that of subtilisin suggested that each convertase possesses a signal peptide followed by a unique prosegment of about 83-90 amino acids. By analogy with prosubtilisin [24] , this prosegment might have to be excised in 736 S. Benjannet and others order to generate an active proteinase [1, [4] [5] [6] [7] [8] [10] [11] [12] 23, 25, 26] . Recent studies with the convertases kexin [27, 28] and furin [29] demonstrated that these two processing enzymes are able to autocatalytically excise their prosegments. In the case of the yeast kexin [27, 28] , this reaction seems to take place within the endoplasmic reticulum (ER), resulting in an active enzyme [30] . In contrast, the ER may not represent a favourable milieu for the efficient autoactivation of furin [31] .
As the rate of removal of the N-terminal prosegment could conceivably represent a mechanism by which the cell could control the efficiency of proprotein processing [23] , we undertook the comparative analysis of the prosegment cleavage of PC1 and PC2 in GH4C1 cells. The cDNA structures of PCI [5, 6] and PC2 [7, 8] predict three potential N-glycosylation sites for each enzyme. Accordingly, we also investigated the potential role of glycosylation in the processing, secretion and activity of these convertases. Our data permit us to define the ER and the transGolgi network as the intracellular sites of pro-PC1 and glycosylated pro-PC2 processing respectively. The mechanism of prosegment cleavage of PC1 and PC2 is not yet known, nor is it defined to be an autocatalytic or heterocatalytic process. Therefore we also investigated the possibility that the ubiquitous convertase furin [17] participates in this zymogen-activation reaction.
MATERIALS AND METHODS
Vaccinia virus recombinants of mouse (m)PC1, human (h)PC1, mPC2, hfurin, mouse pro-oplomelanocortin (mPOMC) and porcine (p)POMC The purified recombinant vaccinia viruses of mPC1 (VV: mPC1) [5] and mouse PC2 (VV:mPC2) [8] were the same as those previously reported [21] . The vaccinia virus recombinant of hPCI (VVtml:hPCI) was prepared from the cDNA of hPC1 [32] using the pTM-1 transfer vector [33] . The recombinant VV: hfurin was prepared using the cDNA of human furin [9] (a gift from Dr. A. Rehemtulla, Genetics Institute, Boston, MA, U.S.A.) subcloned in the pVV3 transfer vector as reported for VY: mPC1 and VV: mPC2 [21] . The vaccinia virus recombinant of mPOMC (VV:mPOMC) was a gift from Dr. G. Thomas (Vollum Institute, Portland, OR, U.S.A.) and that of pPOMC (VV: pPOMC) was obtained as described [34] .
Cellular infections
In this work we have used three types of cells plated on 60 cm2 dishes: a GH4C1 rat somatomammotroph cell line, a flTC3 mouse pancreatic and a Rin m5F rat insulinoma cell line. The vaccinia virus used for infection of all the cells consisted of either the wild-type virus (VV: WT) or the recombinant viruses, and the infections were performed at a multiplicity of infection of 1 plaque-forming unit (p.f.u.)/cell, except for the Wtml:hPC1 where we performed an additional co-infection with 1 p.f.u./cell of VTF7-3 vaccinia virus recombinant which expresses the bacteriophage T7 RNA polymerase [33] . At the end of the pulse or pulse-chase periods, the medium was removed, centrifuged for 10 min at 300 g after the addition of protease inhibitors including: phenylmethanesulphonyl fluoride (100 ,ug/ml), aprotinin (2 ug/ml) and EDTA (1 mM). The cells were washed once in PBS-M (2.7 mM KC1, 1.5 mM KH2PO4, 137 mM NaCl, 4.2 mM Na2HP04 and 1 mM MgCl2), and then lysed in a Nonidet P40 lysis buffer containing 50 mM Tris, 150 mM NaCl, 0.05 % SDS and 1 % Nonidet P40 and the same protease inhibitors as above. The cells were freeze-thawed three times, sonicated for 30 s, centrifuged and the supernatant was immunoprecipitated with either PCI-or PC2-specific antibodies.
Metabolic labelling of cells
In experiments with brefeldin A or tunicamycin, the cells were preincubated for either 60 min or 180 min with 5 ,tg/ml either brefeldin A (Epicentre) or tunicamycin (Sigma), and then pulse and pulse-chase analysis were performed. In experiments with carbonyl cyanide m-chlorophenylhydrazone (CCCP), the cells were first pulse-labelled and then chased in the presence or absence of 40 1uM CCCP (Sigma). In temperature block experiments, the cells were labelled at 37°C and then chased at either 15°C or 37 'C.
Analysis of radiolabelled PCI and PC2
In order to study the secreted and cellular forms of PCI and PC2 radiolabelled with [35S]methionine, the media or cell extracts were immunoprecipitated with either an mPC1 (AbC-mPC1) or an mPC2 (AbC-mPC2) polyclonal antibody directed against the C-terminal segment 629-726 of mPCl [5] or 529-637 of mPC2 [8] respectively as described [23] . For displacement purposes, in some cases before immunoprecipitation, we preincubated the antibodies for about 1 h with 50 /tg of the segments comprising residues 629-726 of mPC1 or 529-637 of mPC2, obtained by thrombin digestion of bacterially produced fusion proteins to glutathione S-transferase [23] . We also analysed the labelled PC 1-related proteins by immunoprecipitation with a polyclonal antibody AbN-mPC1, directed against the N-terminal segment 84-100 of mPCI [5] , which was kindly provided by Dr Using an N-terminally directed mPCl antibody (AbN-mPC 1), which recognizes the first 17 amino acids of PCI (residues 84-100), Vindrolla and Lindberg [36] reported that, in AtT-20 cells, PCl is further slowly cleaved at its C-terminus, resulting in a 66 kDa form. Using the same antiserum, we also immunoprecipitated the supernatant of the AbC-mPCl precipitation presented above (Figure la) . Accordingly, we also detected a 66 kDa form appearing intracellularly in the 8 min pulse, and, like the 83 kDa form, its level peaks at 30 min ( Figure Ib [5] , we conclude that the 83-84 kDa [22] and the 66 kDa forms of PC1 have the same N-termini. As the secreted 66 kDa form is not recognized by our C-terminal antibody, these data agree with the observation of Vindrolla and Lindberg [36] who suggested that it represents PCI truncated at its C-terminus, at an as yet unspecified site. It is important to note that the relative amounts of the various forms of PCI shown in Figure l Pulse-labelling experiments in the presence of Na235SO4 demonstrate that only the 84 kDa form of PCI is sulphated both intracellularly and in the medium. Although it decreased the size of PCI to about 83 kDa, digestion with endoglycosidase F did not diminish the intensity of the label (not shown), suggesting the absence of sulphation on an N-glycosyl moeity. Pro-PCI (88 kDa), the 83 kDa form of PCI and the secreted 66 kDa form recognized by the N-terminal antiserum were not labelled with
[35S]sulphate (not shown). We believe that sulphation occurs at a specific tyrosine residue, as digestion of the sulphated PCI (84 kDa) with arylsulphatase eliminated all the label on this protein (not shown), which also argues for the absence of sulphation on an O-glycosylation site. Furthermore, the lack of sulphation in the 66 kDa form suggests that the sulphation site is within the segment 629-726 of mPCI.
Pulse-chase analysis of the biosynthesis of PC2 In GH.C1 cells
The data from Figure 2 (a) demonstrate, at pulse times as short as 3 or 10 min, the intracellular presence of three PC2-immunoreactive proteins with apparent molecular masses of 75, 70 and 65 kDa. The microsequence of the 75 kDa form indicates that it represents pro-PC2 [23, 35] . The [8] . The SDS/PAGE analysis and autoradiography conditions were identical with those in Figure 1 . proteins ( Figure 2a) Lys-Arg-Arg-Arg84 or Lys-Arg-Arg-Arg5f respectively [8] . However, we also notice that, unlike the PC2 form secreted into the medium [23J, the sequencing yield of these PC2-related intracellular proteins is very low.
Analysis of the intracellular forms obtained after 3 h or 6 h of chase (Figure 2a, [23] (originally reported to migrate at an apparent molecular mass of 65 kDa), the level of which increases with chase time from 3 to 6 h (Figure 2a, lanes 9 and 1 1) . It should be noted that [35S]methionine-labelled PC2 is detectable in the medium only after 2 h of chase (not shown). The microsequence of the 68 kDa form in the medium shows that it represents a PC2 form in which the N-terminal 84-amino-acid segment of pro-PC2 has been removed via cleavage at the predicted second tetrabasic sequence, i.e. after Lys-Arg-Arg-Arg84 1 [8, 23] . In the GH4C1 cell line used in this study, the intracellular 75 kDa pro-PC2 form is still detectable even up to 22 h of chase time (not shown).
As shown in Figure 2( Figure 1 , the processing of pro-PCl to PCl was shown to be both efficient and rapid, suggesting that such a cleavage may occur within the ER and continue in the cis-Golgi compartment. In order to define more precisely the site at which the onset of such a processing step occurs, we used three different treatments that disrupt the transport of proteins from the ER to the Golgi complex. In the first two, we inhibited the migration of pulse-labelled proteins to the Golgi apparatus by chasing the cells either at 15°C [37] or in the presence of CCCP [38] , which depletes the cellular ATP levels and hence blocks the movement of proteins from the ER to the Golgi complex. In the latter treatment we pretreated the cells with the drug brefeldin A, a unique fungal metabolite known to cause disassembly of the Golgi complex and accumulation of secretory proteins in the ER [39] .
Treatments with either brefeldin A (Figure 3a) or CCCP (Figure 3b) did not affect the extent of processing of pro-PCl to PC1, as judged by both N-terminal (not shown) and C-terminal immunoprecipitations. Furthermore, as expected, both drugs blocked the basal secretion ofPC1 into the medium. Interestingly, the intermediate-sized PCI (84 kDa) only appears in the absence of brefeldin A preincubation (Figure 3a, lane 1) . This is consistent with the identification of this 84 kDa form as the trimmed and remodelled PCI protein which has already reached the medial Golgi cisternae.
Although it blocked the basal secretion of PC2, treatment of the GH4C1 cells with brefeldin A (Figure 4a) (Figure 2a ) also show that both forms are Endo H-resistant, supporting the hypothesis that these are not N-glycosylated. Therefore our data suggest that the processing of non-glycosylated pro-PC2 occurs in the ER (Figure 4 ), whereas the processing of the glycosylated (Endo H-sensitive) and sulphated pro-PC2 occurs within the Golgi apparatus (Figure 2b ). Figures 6(a) and 6(b) . The data confirm that pro-PCI (Figure 6a , lanes 1 and 2) and pro-PC2 (Figure 6b, lanes 1 and 2) are N- +T +T +T glycosylated, as tunicamycin reduces their molecular masses by approx. 3-5 kDa. We also note that the non-glycosylated pro-PC2 obtained after tunicamycin treatment migrates as a 70 kDa entity ( Figure 6b, lanes 2 and 4) . These results suggest that the 70 kDa form observed in Figure 2 (a) is non-glycosylated pro-PC2. Unexpectedly, the prevention of N-glycosylation of both PCI and PC2 causes their considerable intracellular degradation (Figure 6a, lanes 2, 4 and 6 and Figure 6b, lanes 2 and 4) . This degradation generates multiple polypeptides of lower molecular mass. The consequence of this degradation is a much reduced level of basally secreted PCI (Figure 6a, lanes 7 and 8) and PC2 (Figure 6b, lanes 5 and 6) . In order to define the organelle in which such degradation occurs, we have also incubated the cells with both tunicamycin and brefeldin A. We observed that both PCI (Figure 6a , lanes 5 and 6) and PC2 (Figure 6b, lanes 3 and  4) are degraded, even in the presence of brefeldin A, suggesting that the observed degradation occurs within the ER. Furthermore, the data also demonstrate that pro-PCI and pro-PC2 are still detectable in the presence of tunicamycin and brefeldin A, suggesting that these proforms are degraded to a much lesser extent than either PCI or PC2.
As earlier experiments [40] demonstrated that tunicamycin does not affect the secretion or cause the degradation of pituitary POMC, we investigated whether the removal of the N-glycosylation of PCI and PC2 can also affect their proven ability to process POMC [21] . As shown in Figure 6 (c), tunicamycin also reduces the molecular mass of POMC by about 3 kDa (lanes 1 and 2). We also observed that the ability to process POMC by either PCI into fl-lipotropin (Figure 6c, lanes 3 and 4) or PC2 into a high-molecular-mass intermediate and /8-endorphin (lanes 5 and 6) is clearly diminished (lanes 4 and 6) . The above data suggest that, although much of the PCI and PC2 synthesized de novo is degraded in the absence of N-glycosylation, there is some residual activity, which enables the processing of POMC. It is also possible that this activity is due in part to the presence of residual glycosylated enzymes synthesized during the overnight infection and before the addition of tunicamycin (see the Materials and methods section). change in the amount of the 65 kDa form. These data suggest that the processed PC2 is preferentially released from the cell and does not accumulate intracellularly. As shown in Figure 7 , when either /?TC3 or Rin m5F cells were infected with W: mPC2 before the pulse-chase labelling, there was a slight increase in the level of pro-PC2 (56 % of the total PC2-immunoprecipitable proteins in both cells), suggesting that cellular infection has a minor effect on the observed extent of cleavage of the prosegment of PC2 (lanes 2 and 4) . These data demonstrate that the observed limited processing of pro-PC2 is not likely to be an artifact or to be caused by the vaccinia virus infection and probably depends on some intrinsic characteristic of this precursor. The results agree with those recently reported by Guest et al. [41] , who showed that in pancreatic islets of Langerhans processing of pro-PC2 seems to proceed to completion within 7 h of the chase. [20] . The SDS/PAGE analysis and autoradiography conditions were identical with those in Figure 1 . Abbreviation: f-LPH, f8-lipotropin.
88 kDa to the 83 kDa form within the first few minutes of synthesis. As shown in Figure 8 , when GH4C1 cells were coinfected with WtmI: hPCl and VTF7-3 and pulsed for 1 2 and 4) . Surprisingly, we also detected much more important amounts of the intracellular pro-hPCI (88 kDa) as compared with pro-mPCI ( Figure 8, lanes 1 and 3) . As expected from the cDNA sequence of hPC1 [32] , the microsequence identification of pro-hPC1 (88 kDa) and hPCI (83 kDa) revealed a Phe-4 and Phe-11 respectively. Therefore, following the predicted signal peptidase cleavage site, pro-hPC1 is cleaved intracellularly at the same Arg-Ser-Lys-Arg I position as pro-mPC1 [23] , to produce hPCl which represents residues 84-726 of pro-hPCl [32] . 
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The SDS/PAGE analysis of the immunoprecipitation of the [35S]methionine 10 min pulse-labelled and 3 h-chased GH4C1 cell extracts and media is shown in Figure 9 . The data show that, intracellularly, the co-expression of furin does not alter the processing of the pro-PCI into PCI (Figure 9a, lanes 1 and 3) and pro-PC2 into PC2 (Figure 9b lanes 1 and 3) . We also note that the levels of secreted PCI (Figure 9a, lanes 2 and 4) or PC2 ( Figure 9b, lanes 2 and 4) are not affected by the presence of overexpressed furin. When a similar experiment was performed in either COS-1 monkey kidney cells or in the rat insulinoma Rin mSF cells, an identical conclusion was reached, i.e. furin does not process either pro-PCI or pro-PC2 (not shown). As a positive control, in these cell lines when either PCI or furin was coexpressed with POMC, we observed the conversion of this precursor into ,-lipotropin (Figure 9c ), as previously reported [23, 42] . Furthermore, the conversion of POMC by either furin or PCI is specific to these convertases, as a similar experiment with PC2 results in the expected formation of fi-endorphin ( Figure   9c ). Therefore the inability of furin to convert either pro-PCI or pro-PC2 into PCI or PC2 reflects the resistance ofthe prosegment of pro-PCI and pro-PC2 to the intracellular cleavage by furin. Figures 1 and 2 show that the initial cleavage of pro-PCI into PCI and of non-glycosylated pro-PC2 into non-glycosylated PC2 occurs as early as 1-3 min from the start of their synthesis. Consistent with the precursor-product relationship of pro-PC1 to PCI, we see a gradual increase in the 83 kDa form of PCI over time ( Figure la) . As it would take about 1-3 min to complete the synthesis of one copy of a protein of the length of PCI or PC2 [43, 44] , it is likely that, within the ER, the prosegment cleavage of pro-PCI occurs co-translationally, or very soon afterwards. Our results suggest that sulphation of PCI and pro-PC2 occurs on a tyrosine residue. From the proposed rules of tyrosine sulphation [45] , we predict that Tyr-694 [5] and Tyr-171 [8] could be the targetted residues in PCI and PC2 respectively. As sulphation on tyrosine residues has been reported to occur within the trans-Golgi network [46] , our data suggest that the processing of sulphated pro-PC2 occurs in this network.
DISCUSSION
In this work, we have demonstrated that the N-terminal propeptide cleavage of PCI occurs in the ER and is more efficient than that of PC2. The processing of pro-PC2 is not favoured in the ER, resulting in longer retention in this organelle of the nonsulphated pro-PC2 than PCI. As efficient exit of proteins from the ER depends on their ability to fold correctly and to form higher-order structures, including oligomerization [44, 47] , the unequal rates of exit of PCI and pro-PC2 from the ER may reflect the effect of the prosegment of PC2 on the rate of folding of this protein.
The inability of functionally active furin (Figure 9c ) to excise the prosegments of PCI and PC2 (Figures 9a and 9b) suggests that either this cleavage occurs autocatalytically, as described for pro-kexin [27, 28] and pro-furin [29, 31] , or another unidentified proteinase is responsible for this processing. We therefore believe that, although furin can autocatalytically cleave its prosegment by an intramolecular mechanism [29, 31] , it is not capable of processing either pro-PCI or pro-PC2. Recently [48] , PCI was shown to efficiently cleave in vitro the decapeptide [D-Tyr]-ArgSer-Lys-Arg l Ser-Val-Gln-Lys-Asp encompassing the Lys-Argjunction between pro-mPCI and mPCI [5] , suggesting that PCI has the capacity to undergo autocatalytic activation.
Proteins synthesized within the ER are transported to the Golgi complex and from there to their final destinations by a complex multistep dissociative transport mechanism [49] . The steps involved in this process have been elucidated by the use of specific drugs or treatments which disrupt transport at defined intracellular locations. For example, low temperature inhibits the transport of pancreatic secretory proteins [50] . Drugs such as CCCP deplete ATP sources and hence block the movement of proteins from the ER to the Golgi complex [38, 51] . Brefeldin A affects early events in the transport of proteins by causing the disassembly of the Golgi complex and accumulation of secretory and cis and medial Golgi-resident proteins in the ER [39] . However, brefeldin A does not cause the relocation of proteins present within and beyond the trans-Golgi network [52] . Our data show that when GH4C1 cells were subjected to either one of these three treatments, the amount of PCI (83 kDa) increased rather than decreased (Figure 3) , suggesting that the excision of the prosegment occurs within the ER. However, we still do not know whether the processed PCI is functionally active within the ER milieu. In experiments aimed at answering such a question for furin, it was shown that the activation of pro-von Willebrand factor [31] or of a mutant mouse pro-renin-2 [53] by furin is not possible in the ER.
The time at which a glycoprotein acquires resistance to digestion by Endo H is often used as a measure of the period required for a protein to travel from the ER to the medial Golgi [54] . The data in Figure 5 (a) demonstrate that it takes less than 1 h for the appearance of the 84 kDa form of PCI that is Endo H-resistant. In contrast, the intracellular pro-PC2 is still Endo H-sensitive after 6 h of chase and the secreted 68 kDa form is also sensitive to Endo H digestion (Figure 5b ). These data highlight a major difference between the structure of the carbohydrate moieties attached to asparagine in PCI and PC2, and further suggest that in PC2 they are of a high mannose type [54] . The importance of the glycosylation of PCI and PC2 (as opposed to POMC) is emphasized by the degradation in ER of the nonglycosylated forms, obtained in the presence of tunicamycin ( Figure 6 ). The nature of the ER resident enzymes responsible for this degradation are not known nor is the possi-ble involvement in this process of heat-shock proteins such as BiP [55] . Our data further suggest that non-glycosylated PCI and PC2 are more rapidly degraded than their proforms ( Figure 6 ). Inhibition of asparagine glycosylation within the ER may either unfold or prevent oligomerization of these enzymes and hence expose them to the proteases that are responsible for clearing unwanted protein structures [55] . It would be informative to compare the relative importance of each one of the predicted three Nglycosylation sites in PCI [5] and PC2 [8] in the protection of these convertases against degradation by ER hydrolases. In this context, it is interesting to note that N-glycosylation is important for the transit of pro-papain through the -secretory pathway of insect Sf9 cells and is a prerequisite for the production and secretion of functional pro-papain [56] .
The major secreted form of PCI (84 kDa) from the GH4C1 cells is enzymically active on a number of peptide substrates in vitro [48] . The transformation of the 83-84 kDa form of PCI into the 66 kDa form occurs rather slowly [36] and the extent to which this occurs is cell type-dependent, e.g. in AtT-20 [36] versus GH4C1 cells (this work). We still do not know whether the 66 kDa form of PCI is active. Furthermore, in view of its late appearance, its intracellular function is not yet clear. We also note that unlike for PC1, no report showed the presence of a Cterminally truncated form of PC2 in any tissue studied [36, 57] . In contrast, immunoblots of rat adrenal medulla also showed the presence of an N-terminally truncated form of PC2 which migrated with an apparent molecular mass of 40 kDa [57] , and which presumably would be inactive as part of the catalytic segment would be missing [7, 8] .
In conclusion, it will take a concerted effort using a battery of antisera specific for various PC forms, various secretagogues, biochemical and electron microscopic analysis, before we can define in more detail the molecular sizes of the enzymes found in each organelle. Further work is necessary to define the various post-translational modifications of the processing enzymes and their effect on the activity and sorting of these convertases. It is hoped that the generation of these data and those obtained from comparative enzymic activity studies of the various forms of PCI, PC2 and furin will lead to a better understanding of the complex process of proprotein and prohormone activation.
